This protocol is judged by an institutional review board, an impartial group that critiques any clinical trials involving individuals. If a study entails a Schedule I drug, after the board approves the protocol as moral, the scientists need to submit an application for an investigational new drug (IND) selection from your FDA.Just take a simple 3-m… Read More